This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II study with capecitabine as monotherapy in...
Clinical trial

Phase II study with capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer

Read time: 1 mins
Last updated:23rd Jun 2006
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest